Atlas Trials

Blinatumomab Consolidation Post Autologous Stem Cell Transplantation in Patients With Diffuse Large B-Cell Lymphoma (DLBCL)

Clinical trial NCT03072771 · COMPLETED

Trial details

NCT number
NCT03072771
Sponsor
Washington University School of Medicine
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Diffuse Large B Cell Lymphoma
Start date
2017-08-01
Primary completion
2021-04-07
Enrollment
14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.